INO Stock Down 23%, Inovio’s Coronavirus Vaccine Candidate Shows Promise in Early Stage Trial
The stock of Inovio Pharmaceuticals is down 23% now despite the company’s announcement of a positive result from its INO-4800 clinical trials.
Why Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics Stocks Took Off on Thursday
By
Darya Rudz
The number of COVID-19 cases is rising again, and the companies working on the vaccine will likely further benefit from a cash flow into them. Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics stocks are good examples of this advantage.
INO Stock Jumps 15% as Inovio Secures Government Funding for COVID-19 Vaccine Device
Inovio has secured funding from the U.S Department of Defense to expedite the development and production of its Cellectra 3PSP Smart Devices for the administration of the COVID-19 vaccine. INO stock is up.
Inovio (INO) Stock Rose 8% Yesterday, Up 5% Now as Hunt for COVID-19 Vaccine Goes On
Inovio (INO) stock was jumped 8% yesterday, is in the green now after the company released its fiscal Q1 earnings report, while it is working on a coronavirus vaccine.
Inovio (INO) Pharmaceuticals Stock Fell 5% as Class Action Lawsuit Brews
By
Tolu Ajiboye
Inovio Pharmaceuticals might see a plunge in its 2020 gains if a class action lawsuit proves the company deliberately misled the public. Yesterday, INO stock lost over 5% of its value.
Inovio (INO) Stock Rises 5.40% Today after 14.55% Loss on Friday
By
Tolu Ajiboye
While the company has had great gains as it works on a COVID-19 vaccine, Inovio (INO) stock fell last Friday, was down in the-premarket today but is up as trading began.
INO Stock Up 4% Now, Inovio to Recruit All Coronavirus Vaccine Volunteers by End of April
By
Darya Rudz
Thanks to the progress in the vaccine development, Inovio (INO) stock has given a boost to investor confidence. Since the end of 2019, Inovio shares are 264,55% up. In the last month alone, the rise is 65%.
Why Inovio Pharmaceuticals (INO) Stock Is Top Performer among Coronavirus Vaccine Stocks
By
Tolu Ajiboye
At the moment, Inovio (INO) is probably the best performing stock among the biotech companies, with over 300% gains. Let’s take a look at the reasons why this is so.